Clinical trial
Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus…
NCT00362297 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00362297 |
|---|---|
| Title | Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 |
| Official title | A Randomized, Cross-Over Study to Evaluate the Suppressive Effect of High-Dose Acyclovir Versus Once Daily Valacyclovir on Herpes Simplex Virus Type 2 Genital Shedding in Herpes Simplex Virus-2 Seropositive Adults |
| Lead sponsor | University of Washington, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Genital Herpes |
| Intervention type | Drug |
| Interventions | acyclovir, valacyclovir |
| Enrollment | 31 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Sep 1, 2011 |
| First posted | Aug 9, 2006 |
| Last update posted | Nov 18, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: